首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1)
【2h】

Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1)

机译:脑酸可溶性蛋白1(BASP1)对Myc诱导的细胞转化的抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cell transformation by the Myc oncoprotein involves transcriptional activation or suppression of specific target genes with intrinsic oncogenic or tumor-suppressive potential, respectively. We have identified the BASP1 (CAP-23, NAP-22) gene as a novel target suppressed by Myc. The acidic 25-kDa BASP1 protein was originally isolated as a cortical cytoskeleton-associated protein from rat and chicken brain, but has also been found in other tissues and subcellular locations. BASP1 mRNA and protein expression is specifically suppressed in fibroblasts transformed by the v-myc oncogene, but not in cells transformed by other oncogenic agents. The BASP1 gene encompasses 2 exons separated by a 58-kbp intron and a Myc-responsive regulatory region at the 5′ boundary of untranslated exon 1. Bicistronic expression of BASP1 and v-myc from a retroviral vector blocks v-myc-induced cell transformation. Furthermore, ectopic expression of BASP1 renders fibroblasts resistant to subsequent cell transformation by v-myc, and exogenous delivery of the BASP1 gene into v-myc-transformed cells leads to significant attenuation of the transformed phenotype. The inhibition of v-myc-induced cell transformation by BASP1 also prevents the transcriptional activation or repression of known Myc target genes. Mutational analysis showed that the basic N-terminal domain containing a myristoylation site, a calmodulin binding domain, and a putative nuclear localization signal is essential for the inhibitory function of BASP1. Our results suggest that down-regulation of the BASP1 gene is a necessary event in myc-induced oncogenesis and define the BASP1 protein as a potential tumor suppressor.
机译:Myc癌蛋白的细胞转化分别涉及具有内在致癌或肿瘤抑制潜能的特定靶基因的转录激活或抑制。我们已经确定BASP1(CAP-23,NAP-22)基因是Myc抑制的新型靶标。酸性25kDa BASP1蛋白最初是从大鼠和鸡脑中作为皮质细胞骨架相关蛋白分离出来的,但也已在其他组织和亚细胞位置中发现。在由v-myc致癌基因转化的成纤维细胞中,BASP1 mRNA和蛋白质的表达受到特异性抑制,而在由其他致癌剂转化的细胞中则没有受到抑制。 BASP1基因包含2个外显子,它们由58 kbp内含子和未翻译外显子1的5'边界处的Myc响应调节区隔开。BASP1和v-myc的双顺反子表达来自逆转录病毒载体,阻断了v-myc诱导的细胞转化。此外,BASP1的异位表达使成纤维细胞对随后的v-myc细胞转化具有抗性,而BASP1基因向v-myc转化细胞中的外源传递导致转化表型的显着减弱。 BASP1对v-myc诱导的细胞转化的抑制作用还可以阻止已知Myc靶基因的转录激活或抑制。突变分析表明,含有肉豆蔻酰化位点,钙调蛋白结合结构域和推定的核定位信号的基本N末端结构域对BASP1的抑制功能至关重要。我们的结果表明BASP1基因的下调是myc诱导的肿瘤发生中的必要事件,并将BASP1蛋白定义为潜在的肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号